2021 FUTURES: Keynote Panel
An inspiring conversation about living in the moment with a rare diagnosis.
An inspiring conversation about living in the moment with a rare diagnosis.
Let’s discuss:
Duchenne Mother, Grandmother and Advocate
4 Jake's Sake | CureDuchenne
Occupational Therapist III
Children’s Health and Rehabilitation Services
Pediatric Neurologist
Arkansas Children's Hospital
Medical Director, Pulmonary Function Testing Laboratory Children's Hospital of Philadelphia
Pediatric Cardiologist Fetal Care Center Dallas | Neurology and Neuromuscular Care Center
How to talk to others about unique challenges like marriage and family dynamics, talking to your kids about Duchenne, and other everyday obstacles that many families in this community face.
Pediatric Neurologist
Arkansas Children's Hospital
Pediatric Gastroenterologist
Nationwide Children's Hospital
Medical Director, Pulmonary Function Testing Laboratory Children's Hospital of Philadelphia
Pediatric Cardiologist Fetal Care Center Dallas | Neurology and Neuromuscular Care Center
CureDuchenne Certified Physical Therapist
CureDuchenne Physical Therapy Program
Occupational Therapist III
Children’s Health and Rehabilitation Services
Pediatric Urologist
University of Iowa Stead Family Children's Hospital
Post Doctoral Fellow
University of Arkansas for Medical Sciences
Quantum Product & Technical Education Manager
Pride Mobility
A session about how to get involved with CureDuchenne Link.
Learn more about CureDuchenne Link and how to participate please visit: cureduchenne.org/cureduchenne-link
A warm welcome from the Miller Family, and an informative presentation on CureDuchenne’s timeline of contributions and investments, and how these inform our future vision.
The science and research-focused day of FUTURES will begin with an engaging keynote panel featuring key opinion leaders who will discuss the successes, learnings, challenges, and future of this disease space.
Vice President, Disease Area Executive, DMD
Vertex Pharmaceutical
Chief, Neuromuscular and Neurogenetic Disorders of Childhood Section National Institute of Neurological Disorders and Stroke/NIH
Director, Center for Gene Therapy Nationwide Children's Hospital
A brief primer on the gene therapy and gene editing approach to treating Duchenne, and updates from relevant companies in the space. These presentations will be followed by a moderated Q&A opportunity.
Vice President, Disease Area Executive, DMD
Vertex Pharmaceutical
Senior Director of Clinical Science Solid Biosciences
Vice President, Head of Clinical Development Sarepta Therapeutics